JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Derived and engineered immune cells, including T cells and NK cells, present exciting potential for use in cancer immunotherapies. Generation of functional T cells from hPSCs allows for potential off-the-shelf T cell therapies, while genetically engineered CAR T cells enable targeted immunotherapy treatments.
Explore our portfolio of classical media, serum, small molecules, and proteins to support your T cell and NK cell workflows.
Items 11-14 of 14
Recombinant human TGF-beta 1 (TGF-β 1) protein containing 112 amino acids expressed in HEK293 cells for improved protein activity and proper post-translational modifications.
Thiazovivin is a novel ROCK inhibitor with IC50 of 0.5 μM in a cell-free assay, promotes hESC survival after single-cell dissociation. Improves the efficiency of fibroblast reprogramming and induction of iPSCs.
Thiazovivin (GMP-grade) is a novel ROCK inhibitor that promotes hESC survival after single-cell dissociation. Improves the efficiency of fibroblast reprogramming and induction of iPSCs. This small molecule is produced under GMP guidelines making it ideal for cell therapy research.
Z-VAD-FMK is a cell-permeable, irreversible pan-caspase inhibitor. Inhibits caspase processing and apoptosis induction in tumor cells.
Download our latest product guide to learn about all the cell culture products we offer including media, salt solution, plasticware, FBS, HPL, and more.
